From Fear to Facts: Rewriting the Story of Perimenopause, Menopause, and Hormone Therapy

If you’ve ever felt confused, dismissed, or even a little scared when it comes to hormones, perimenopause, or menopause, you are not alone.

For decades, one major study has shaped how doctors talk about hormone therapy, how the media reports on it, and how women feel about their options in midlife. That study is finally being reexamined with better science, better context, and more honest conversation.

To unpack all of this, I sat down with Dr. LaKeischa Webb McMillan, a physician, educator, and the powerful voice behind The Apology Tour: a movement centered on truth, accountability, and rewriting the narrative around women’s health.

Before we got into the data, we started with the heart of it all.

Why “The Apology Tour” Exists

I asked Dr. LaKeischa a simple but important question:

“Can you tell us why you created The Apology Tour and what inspired this movement?”

She explained that The Apology Tour grew out of years spent watching women suffer needlessly:
women who were dismissed, misinformed, or outright scared away from treatments that might have helped them.

Instead of being met with clear, evidence-based guidance, many were given:

• Vague warnings
• Outdated talking points
• Or a flat “no” with no real explanation

The Apology Tour is her response to that legacy.

It’s a call to say, “We got some of this wrong. You deserved better. And we’re going to do better now.”

At its core, the movement is about:

• Truth: Looking honestly at the data and where it was misinterpreted
• Accountability: Owning the impact those misinterpretations had on real lives
• Repair: Helping women reclaim agency, options, and confidence in their own care

With that grounding in place, we moved into the study that started so much of this: the WHI.

What Was the WHI Study and Why Did It Matter So Much?

To get everyone on the same page, I asked:

“Can you help us understand what the WHI Study was and why it became so influential?”

The Women’s Health Initiative (WHI) was a large, federally funded research program launched in the 1990s to look at major health issues affecting postmenopausal women. One arm of the WHI focused on hormone therapy and its impact on risks like heart disease, stroke, and breast cancer.

Because of its size and funding, the WHI quickly became the reference point for hormone therapy conversations. Headlines seized on early findings, and the narrative that followed was blunt and frightening:

• “Hormones cause cancer.”
• “Hormone therapy is too dangerous.”
• “Women should get off hormones immediately.”

Those soundbites traveled faster than the nuances. The problem? The story was far more complex than the headlines suggested.

The WHI looked at a very specific group of women, using specific hormone formulations, in specific doses, starting at a specific time in their lives. But the results were often applied as if they were a universal rule for all women, at all ages, in all circumstances.

That disconnect set the stage for decades of confusion.

The Fallout: How One Study Changed Everything

Next, I asked Dr. LaKeischa to walk us through the aftermath:

“What happened after the WHI Study that created so much confusion and fear about hormones?”

Her answer was sobering.

Almost overnight:

• Many women were told to stop their hormone therapy, sometimes abruptly
• Providers became hesitant or outright refused to prescribe hormones
• Fear-based messaging spread through news outlets and exam rooms alike

The impact on women’s lives was enormous:

• Hot flashes, night sweats, and sleep disruption returned with a vengeance
• Mood changes, brain fog, and vaginal dryness went untreated
• Some women felt betrayed, whiplashed by shifting advice and fearful for their health

Instead of a measured, context-rich conversation, we got a culture of caution driven by worst-case scenarios and incomplete interpretations.

For many women, the takeaway became:
Hormones are dangerous. Full stop.

That belief stayed lodged in the collective consciousness, long after researchers and clinicians began to reexamine the data with more nuance.

A Turning Point: The FDA Removes the Black Box Warning

Today, something important is shifting.

So I asked:

“Why is there so much excitement among clinicians about the removal of the black box warning and what does this mean for women?”

For years, estrogen products carried a prominent “black box warning” from the FDA. It was the most serious type of warning label, meant to highlight potentially severe risks. In practice, it also reinforced a culture of fear around hormone therapy, for both patients and many clinicians.

The removal of that black box warning is not about pretending risk doesn’t exist. It’s about aligning the messaging with what more current evidence actually shows when hormone therapy is:

• Prescribed thoughtfully
• Given in the right form and dose
• Started at an appropriate time in a woman’s health journey

For clinicians, this change is:

• A validation that the science has evolved
• A signal that individualized care is not only allowed, but encouraged
• An opening to have fuller, more accurate conversations with patients

For women, it means:

• The door is reopening for hormone therapy to be discussed as one tool among many
• There is more space to talk about benefits as well as risks
• You can ask questions without feeling like you’re stepping into forbidden territory

It doesn’t mean hormones are right for everyone. It does mean we can finally start talking about them in a way that reflects what we now know, not just what we once feared.

From Fear to Facts: Rewriting the Menopause Narrative

To close our conversation, I asked Dr. LaKeischa:

“How does this announcement help us move from fear to facts and start a healthier conversation about midlife hormones?”

This moment is bigger than a label change. It’s an opportunity to rewrite the story women have been told about midlife, hormones, and their own bodies.

Here’s what that new narrative can include:

• Menopause is a natural transition, not a personal failure or a disease.
• You deserve options. Hormone therapy may be one of them, but not the only one.
• Decisions should be individualized, not dictated by outdated one-size-fits-all rules.
• Fear is not informed consent. You need clear information, not scare tactics.

Moving from fear to facts means:

• Asking better questions in the exam room
• Expecting your provider to explain risks and benefits in context
• Recognizing that science evolves, and it’s okay to update our choices as evidence changes

This is where conversations like The Apology Tour matter so deeply. They give language to what so many women have felt: the grief of being misled, the anger of being dismissed, and the hope of finally being seen and heard.

A Closing Reminder for Every Woman in Midlife

This conversation is a powerful reminder that science evolves, but the stories we tell about that science don’t always keep up.

Dr. LaKeischa Webb McMillan is helping change that. By revisiting the WHI legacy, challenging outdated narratives, and celebrating milestones like the removal of the black box warning, she’s helping create a more honest, hopeful, and evidence-based path forward.

Here’s what I want you to take away:

• You deserve accurate information, not oversimplified fear.
• You deserve informed choices, not blanket statements.
• You deserve care rooted in current evidence, not in decades-old headlines.

If this conversation sparked questions, curiosity, or even a little fire in you, that’s a good thing. That’s often where better health begins: not with blind trust or blind fear, but with thoughtful, informed questions.

Thank you for reading, for caring about your health, and for being willing to rethink old stories. The conversation about perimenopause, menopause, and hormones is far from over.

We’re just beginning to tell it more truthfully.